Metrics to compare | 688114 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship688114PeersSector | |
|---|---|---|---|---|
P/E Ratio | −137.3x | 18.5x | −0.4x | |
PEG Ratio | −1.87 | 0.51 | 0.00 | |
Price/Book | 3.1x | 3.0x | 2.6x | |
Price / LTM Sales | 7.5x | 5.3x | 3.0x | |
Upside (Analyst Target) | 32.1% | 33.8% | 52.8% | |
Fair Value Upside | Unlock | −10.0% | 9.7% | Unlock |
MGI Tech Co., Ltd. engages in the research, development, production, and sale of instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally. Its products include sequencer products, such as DNBSEQ sequencers, cycloneSEQ sequencers, and sequencing consumables; generative lab intelligence, including sample pretreatment, nucleic acid extraction, universal pipetting, consumables, integrated platforms, intelligent digital platform, and sample preparations; and Multi-Omics, such as cell omics, STOmics, preteomics, PopOmics, sample preparation regeants, microbiomics, agriculture and food safety, public health, environment and biodiversity, ultrasound, bio-fragment analyzer, sample storage, and fluorometer products. MGI Tech Co., Ltd. was founded in 2016 and is headquartered in Shenzhen, China.